In recent years, a variety of biomaterial implantable devices has been developed. Of
particular significance to pharmaceutical sciences is the progress made on the development …

In recent years, a variety of devices (drug-eluting stents, artificial organs, biosensors,
catheters, scaffolds for tissue engineering, heart valves, etc.) have been developed for …

A cell delivery strategy was investigated that was hypothesized to enable magnetic targeting
of endothelial cells to the steel surfaces of intraarterial stents because of the following …

The strict control of cell recruitment during the physiological inflammatory response fails in
autoimmune inflammatory diseases. The chemokine system is a complex and redundant …

Drug Eluting Stents (DES) constitute the current standard of care for the treatment of
restenotic lesions 1-4. Whereas the stent, the drug and the delivery system are all important …

Stent-based drug delivery system is a revolutionary approach to mitigate the negative affects
of balloon angioplasty, improve immune responsiveness and prevent hyperplastic growth of …

Biomaterials developed using sustainable methods and non-toxic solvents have been
effectively applied as eco-friendly, sustainable reaction medium and catalysts for biological …

Drug‐eluting stents have proven superior to bare metal stents with lower restenosis rates.
Local delivery of drugs from these stents is achieved in most cases with the help of biostable …

Background—Emerging drug-eluting stent technologies are evolving toward the elimination
of polymeric component used as the method for modulating drug delivery. Although this …

The major objective of the present study was to develop an accelerated in vitro release
method for everolimus/poly (lactic-co-glycolic acid)(PLGA) biodegradable DES that reflects …